PEN — Penumbra Inc

—
NYSE · Health Care · Health Care Equipment & Supplies · CIK 1321732 ·
Last close
$319.11
Market Cap
$12.58B
52W High
$362.41
52W Low
$276.01
ADV30
373,053
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 390,046,000 264,944,000 41,039,000 34,811,000 1,974,723,000 205,271,000 443,957,000
Mar 2026 374,758,000 253,411,000 38,234,000 32,584,000 1,898,438,000 241,289,000 424,626,000
Dec 2025 385,385,000 262,128,000 59,233,000 47,343,000 1,826,519,000 186,897,000 398,916,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$277,802,000
Investing CF
$-510,232,000
Financing CF
$16,125,000
CapEx
$-61,896,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$3.97
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$305,086,000
Inventory
$442,650,000
Receivables
$190,407,000
ST Investments
$453,524,000
EBIT TTM
$205,131,000
Pretax Income TTM
$203,832,000
Interest Exp TTM
$1,299,000
Analysts
13

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,560,333,952
EBITDA
$209,160,992
Free Cash Flow
$166,086,496
Enterprise Value
$12,106,995,712
Total Cash
$673,612,032
Total Debt
$209,390,000
Shares Out
39,414,385
Trailing EPS
$3.97
Book Value
$40.18
ROE
10.7%
ROA
6.3%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 1,403,665,000 189,249,000 177,687,000 1,826,519,000 398,916,000 1,427,603,000 238,663,000
Dec 2024 1,194,615,000 86,224,000 14,012,000 1,533,181,000 382,250,000 1,150,931,000 168,481,000
Dec 2023 1,058,522,000 91,766,000 90,954,000 1,556,305,000 377,361,000 1,178,944,000 97,333,000
Dec 2022 847,133,000 6,082,000 -2,002,000 1,370,886,000 372,028,000 998,858,000 -55,661,000

TTM Snapshot

Revenues TTM
$1,504,874,000
NetIncome TTM
$160,589,000
OpCashFlow TTM
—
Assets (Latest)
$1,974,723,000
Forward EPS
$6.10

Max Pain — expiry 2026-12-18

max pain strike: $350.00 · spot: $320.60 · call oi: 974 · put oi: 3,186
Expected Move to 2026-12-18: ±$18.60 (5.80%) — implied range $302.00 – $339.20 · ATM straddle on $320.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
SNN SMITH & NEPHEW PLC $12.77B $30.51 —
SNNUF SMITH & NEPHEW PLC $12.93B $15.45 —
BAX BAXTER INTERNATIONAL INC $13.33B $25.76 —
ALGN ALIGN TECHNOLOGY INC $11.52B $163.46 —
GKOS GLAUKOS Corp $14.40B $243.25 —

News headlines (Yahoo Finance, 1h cache)

Penumbra (PEN) Stock Faces Q3 Earnings Valuation Scrutiny
2026-10-31 14:13 · Yahoo
Penumbra: Q3 Earnings Snapshot
2026-10-29 20:27 · Yahoo
Penumbra, Inc. Reports Third Quarter 2026 Financial Results
2026-10-29 20:05 · Yahoo
Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
2026-10-20 13:00 · Yahoo
Penumbra (PEN) Clinical Data Puts Its Valuation Back In Focus
2026-10-08 16:20 · Yahoo
New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism
2026-10-06 13:00 · Yahoo
IART vs. PEN: Which Stock Is the Better Value Option?
2026-10-01 14:40 · Yahoo
IART or PEN: Which Is the Better Value Stock Right Now?
2026-09-29 14:40 · Yahoo
S&P revises Boston Scientific outlook to negative on franchise pressures
2026-11-06 22:28 · Yahoo
Boston Scientific Q3 Earnings Call Highlights
2026-10-29 06:04 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.